Scarica l'app Stockscreener
0.18
5.88%
0.010
Lyra Therapeutics Inc Azioni (LYRA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
264.38%
0.532
|
0.146 | 0.544 | 0.458 | 0.41 |
Operating Expenses
|
44.72%
24.06
|
16.62 | 17.37 | 16.96 | 17.72 |
| Benefits Costs and Expenses |
50.28%
22.97
|
15.29 | 16.18 | 16.06 | 16.65 |
| Costs And Expenses |
50.28%
22.97
|
15.29 | 16.18 | 16.06 | 16.65 |
| Operating Income/Loss |
42.77%
-23.52
|
-16.48 | -16.83 | -16.50 | -17.31 |
| Nonoperating Income/Loss |
18.83%
1.086
|
1.338 | 1.192 | 0.897 | 1.072 |
| Income/Loss From Continuing Operations Before Tax |
48.21%
-22.44
|
-15.14 | -15.63 | -15.61 | -16.24 |
| Income Tax Expense/Benefit |
17.65%
0.014
|
0.017 | 0.016 | 0.012 | 0.014 |
| Income/Loss From Continuing Operations After Tax |
48.14%
-22.45
|
-15.16 | -15.65 | -15.62 | -16.25 |
|
Net Income/Loss
|
48.14%
-22.45
|
-15.16 | -15.65 | -15.62 | -16.25 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,537%
64.01
|
3.9096 | 56.95 | 43.68 | 36.83 |
| Diluted Average Shares |
1,537%
64.01
|
3.9096 | 56.95 | 43.68 | 36.83 |
| Basic Earnings Per Share |
59.09%
-0.35
|
-0.22 | -0.27 | -0.36 | -0.44 |
| Diluted Earnings Per Share |
59.09%
-0.35
|
-0.22 | -0.27 | -0.36 | -0.44 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):